将优化的COVID-19疫苗计划带给免疫受损人群 (BOOST-IC):适应性随机对照临床试验的研究协议
David W J Griffin1, Michael Dymock2, Germaine Wong3,4,5
1Department of Infectious Diseases, Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia. d.griffin@alfred.org.au.
Trials
|July 17, 2024
概括
这项研究调查了澳大利亚免疫力低下个体的最佳COVID-19疫苗增强剂计划. 额外的疫苗剂量可以改善免疫反应,这对这个脆弱的人群至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 传染性疾病 传染性疾病
背景情况:
- 免疫功能低下的主体 (ICH) 面临更高的COVID-19突破性感染和严重结果的风险.
- 目前的预防性抗体疗法存在局限性,需要有效的疫苗接种策略.
- COVID-19疫苗在ICH中显示效率降低,但增强剂量可以增强免疫反应.
研究的目的:
- 评估不同COVID-19疫苗增强剂策略的免疫性和安全性,用于澳大利亚的免疫功能低下个体.
- 确定最佳的疫苗接种计划,以改善脆弱人群中对SARS-CoV-2的幽默和细胞免疫力.
主要方法:
- 一个适应性随机试验 (BOOST-IC) 评估一个或两个额外的COVID-19疫苗剂量.
- 参与者包括艾滋病毒感染者,实体器官移植接受者和患有血液性恶性瘤的人.
- 主要结局:抗尖峰SARS-CoV-2IgG的几何平均度在接种疫苗后28天;次要结局包括血清转化率和安全性.
主要成果:
- 本部分应在研究结果可用后填写.
结论:
- 这项研究将提供有关免疫功能低下个体COVID-19疫苗反应的关键数据.
- 研究结果将为艾滋病毒,SOT或血液恶性瘤患者群体开发安全和优化的疫苗计划提供信息.
相关概念视频
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Immunodeficiency Diseases
933
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
933
Drug Administration and Therapy Phases: Overview
444
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
444
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Vaccinations
44.3K
Overview
44.3K


